{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:50Z","timestamp":1790685890495,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090739","type":"journal-article","created":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T22:26:03Z","timestamp":1393626363000},"page":"e90739","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":79,"title":["Luteolin Inhibits Human Keratinocyte Activation and Decreases NF-\u03baB Induction That Is Increased in Psoriatic Skin"],"prefix":"10.1371","volume":"9","author":[{"given":"Zuyi","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalini","family":"Vasiadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Therianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoharis C.","family":"Theoharides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000342140","article-title":"Dopamine agonists upregulate IL-6 and IL-8 production in human keratinocytes","volume":"19","author":"AC Parrado","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2013a possible target for novel therapies?","volume":"58","author":"M Canavese","year":"2010","journal-title":"J Dermatol Sci"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC <etal>et al<\/etal>..(2013) Key Role of CRF in the Skin Stress Response System. Endocr Rev.","DOI":"10.1210\/er.2012-1092"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000246359","article-title":"Mast cells in psoriasis","volume":"192","author":"SO \u00d6zdamar","year":"1996","journal-title":"Dermatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"MP Schon","year":"2005","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-008-0874-x","article-title":"Is there a role for mast cells in psoriasis?","volume":"300","author":"IT Harvima","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1517\/14656560802653198","article-title":"Treatment strategies for early psoriatic arthritis","volume":"10","author":"I Olivieri","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"FO Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/1523-1747.ep12360119","article-title":"Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes","volume":"101","author":"CL Kutsch","year":"1993","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.4049\/jimmunol.171.9.4830","article-title":"IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells","volume":"171","author":"K Kandere-Grzybowska","year":"2003","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1073\/pnas.86.16.6367","article-title":"Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliveration of cultured human keratinocytes","volume":"86","author":"RM Grossman","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.0022-202X.2003.22140.x","article-title":"Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis","volume":"122","author":"M Detmar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"PF Lizzul","year":"2005","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clindermatol.2003.08.015","article-title":"Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis","volume":"21","author":"FC Victor","year":"2003","journal-title":"Clin Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2011.04.010","article-title":"Anti-TNF therapy: safety aspects of taking the risk","volume":"10","author":"H Rosenblum","year":"2011","journal-title":"Autoimmun Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3899\/jrheum.100995","article-title":"Does anti-tumor necrosis factor-alpha therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis?: a review of longterm data","volume":"38","author":"EC Keystone","year":"2011","journal-title":"J Rheumatol"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kimball AB, Papp KA, Wasfi Y, Chan D, Bissonnette R <etal>et al<\/etal>..(2012) Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study. J Eur Acad Dermatol Venereol.","DOI":"10.1111\/jdv.12046"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157016309789869092","article-title":"Current treatment of psoriasis with biologics","volume":"6","author":"M Kunz","year":"2009","journal-title":"Curr Drug Discov Technol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"KA Papp","year":"2012","journal-title":"N Engl J Med"},{"key":"ref20","first-page":"247","article-title":"Botanicals in dermatology: an evidence-based review","volume":"11","author":"J Reuter","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0031-6997(24)01472-8","article-title":"The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer","volume":"52","author":"EJ Middleton","year":"2000","journal-title":"Pharmacol Rev"},{"key":"ref22","first-page":"119","article-title":"Anti-inflammatory actions of flavonoids and structural requirements for new design","volume":"14","author":"TC Theoharides","year":"2001","journal-title":"Int J Immunopath Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jdermsci.2011.01.002","article-title":"Quercetin inhibits UV irradiation-induced inflammatory cytokine production in primary human keratinocytes by suppressing NF-kappaB pathway","volume":"61","author":"FT Vicentini","year":"2011","journal-title":"J Dermatol Sci"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A <etal>et al<\/etal>..(2012) Quercetin is more effective than cromolyn in blocking human mast cell cytokine release and inhibits contact dermatitis and photosensitivity in humans. PloS One 7.","DOI":"10.1371\/journal.pone.0033805"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.jid.5701059","article-title":"Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis","volume":"128","author":"N Belso","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/039463200902200423","article-title":"Proinflammatory cytokine production in HaCaT cells treated by eosin: implications for the topical treatment of psoriasis","volume":"22","author":"A Zampetti","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-4632.2011.05154.x","article-title":"The roles of cells and cytokines in the pathogenesis of psoriasis","volume":"51","author":"S Coimbra","year":"2012","journal-title":"Int J Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd1607","article-title":"Psoriasis: emerging therapeutic strategies","volume":"4","author":"AB Gottlieb","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jnutbio.2011.03.010","article-title":"Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells","volume":"23","author":"G Notas","year":"2012","journal-title":"J Nutr Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1523-1747.2003.12612.x","article-title":"Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes","volume":"121","author":"B Zbytek","year":"2003","journal-title":"J Inves Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cell.2011.02.023","article-title":"NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-alpha feedforward signaling","volume":"145","author":"S Biton","year":"2011","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.cr.7290259","article-title":"Molecular mechanism of TNF signaling and beyond","volume":"15","author":"ZG Liu","year":"2005","journal-title":"Cell Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-kappaB: an essential transcription factor in psoriasis","volume":"69","author":"AM Goldminz","year":"2013","journal-title":"J Dermatol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"M Laplante","year":"2012","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bcp.2009.06.097","article-title":"Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation","volume":"78","author":"RC Dello","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1038\/jid.2008.122","article-title":"Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease","volume":"128","author":"CN Young","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-4362.2001.01262.x","article-title":"Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin","volume":"40","author":"WY Jiang","year":"2001","journal-title":"Int J Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2011.02.005","article-title":"Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis","volume":"127","author":"B Zhang","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/381021a0","article-title":"The two faces of the mast cell","volume":"381","author":"SJ Galli","year":"1996","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2222.2000.00768.x","article-title":"Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells","volume":"30","author":"M Kimata","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1742-2094-9-85","article-title":"Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin","volume":"9","author":"S Asadi","year":"2012","journal-title":"J Neuroinflam"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bcp.2004.05.012","article-title":"The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells","volume":"68","author":"R Verbeek","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjp.2008.356","article-title":"Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell dependent stimulation of Jurkat T cells","volume":"155","author":"D Kempuraj","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"13","author":"BJ Nickoloff","year":"2007","journal-title":"Nat Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.fct.2007.05.015","article-title":"A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic\/carcinogenic properties","volume":"45","author":"M Harwood","year":"2007","journal-title":"Food Chem Toxicol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1089\/ars.2005.7.1728","article-title":"Evaluation for safety of antioxidant chemopreventive agents","volume":"7","author":"S Kawanishi","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"T105","DOI":"10.1111\/j.1750-3841.2010.01702.x","article-title":"Toxicity study of ethanolic extract of Chrysanthemum morifolium in rats","volume":"75","author":"L Li","year":"2010","journal-title":"J Food Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.etp.2008.12.005","article-title":"Dose- and time-dependent effects of luteolin on carbon tetrachloride-induced hepatotoxicity in mice","volume":"61","author":"R Domitrovic","year":"2009","journal-title":"Exp Toxicol Pathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.tox.2013.05.015","article-title":"Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney","volume":"310","author":"R Domitrovic","year":"2013","journal-title":"Toxicology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/01635580903285098","article-title":"Dietary polyphenols, inflammation, and cancer","volume":"61","author":"W Guo","year":"2009","journal-title":"Nutr Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/138955709787001712","article-title":"Distribution and biological activities of the flavonoid luteolin","volume":"9","author":"M Lopez-Lazaro","year":"2009","journal-title":"Mini Rev Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T23:31:32Z","timestamp":1746142292000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090739"}},"subtitle":[],"editor":[{"given":"Andrzej T.","family":"Slominski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090739","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,28]]}}}